Naluri, a Malaysian healthtech firm has raised US$5 million in a Series-B funding round to support its expansion into the Philippines and Vietnam while accelerating its path to profitability. The funding was led by TELUS Global Ventures through its Pollinator Fund for Good, with additional backing from existing investors including Sumitomo Corporation Equity Asia and M Venture Partners. This latest investment brings the company’s total Series-B funding to US$14 million.
Strengthening regional presence
Naluri’s Group Chief Executive Officer and Co-Founder, Azran Osman-Rani, stated that the funding will be primarily used for working capital and market expansion in Asia, to achieve profitability within the following year. The company also aims to expand its coverage to one million lives across the region.
“We are deeply honoured to have won the trust of our investors to scale this business model and reach the 1 million lives covered milestone,” said Azran. “I’m extremely proud of my team, who stood together through the macroeconomic storms of the past couple of years, battened down the hatches to deliver consistent positive unit economics in this period. We’ve emerged stronger and battle-hardened, ready for smarter market expansion.”
Naluri has already established a strong presence in Indonesia and Malaysia, working with clients across various industries, including banking, insurance, energy, mining, telecommunications, technology, logistics, and professional services. It has also expanded into Singapore and Thailand, offering services that integrate mental health support, chronic disease management, behavioural health prevention, health screenings, promotional programmes, multidisciplinary health coaching, and 24/7 crisis support.
Investor confidence and partnerships
Terry Doyle, Managing Partner at TELUS Global Ventures, said the investment aligns with TELUS’ commitment to advancing workplace mental health solutions globally.
“Our investment in Naluri allows us to expand our footprint in Southeast Asia while also demonstrating TELUS’ strategic commitment to leading the evolution of workplace mental health solutions globally,” Doyle said. “Naluri’s comprehensive approach to employee wellbeing, combined with their innovative programmes that integrate mental health, preventive behavioural health, and chronic disease management, positions them perfectly to address the growing demand for holistic health solutions in the workplace across Southeast Asian markets.”
In addition to its equity investment, TELUS Health has entered into a commercial partnership with Naluri. This collaboration will see TELUS Health deliver its Employee Assistance Programme services, supported by Naluri, across eight Southeast Asian markets. The agreement marks both a financial endorsement and a strategic alignment between the two companies, aimed at expanding digital health innovation and access throughout the region.
The involvement of TELUS Global Ventures through its Pollinator Fund for Good underscores a growing trend among investors to pursue both commercial outcomes and measurable social impact, particularly in the digital health sector.
Meeting growing demand for holistic health solutions
Naluri’s fundraising comes at a time of heightened corporate focus on employee health and wellbeing in Southeast Asia. Industries ranging from finance to logistics are increasingly seeking scalable solutions that address mental health and chronic disease prevention, while also helping manage rising medical costs and supporting workforce productivity.
The company’s approach combines digital platforms with professional coaching and clinical oversight to deliver personalised interventions and measurable health outcomes. Naluri also provides analytics tools that enable employers and insurers to evaluate the economic value of health improvement programmes.
With strong backing from both new and existing investors, Naluri is preparing to expand its multidisciplinary health programmes to new enterprise clients and employee populations in the Philippines and Vietnam in the months ahead, further strengthening its position in Southeast Asia’s growing digital health sector.
